| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2007 | EP1773998A2 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 04/18/2007 | EP1773890A1 Process for the preparation of low molecular weight heparin |
| 04/18/2007 | EP1773862A1 Estrogen receptor modulators |
| 04/18/2007 | EP1773857A1 Immunostimulatory sirna molecules and uses therefor |
| 04/18/2007 | EP1773855A1 Novel compounds that inhibit factor xa activity |
| 04/18/2007 | EP1773854A2 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 04/18/2007 | EP1773850A2 Prodrugs of hiv protease inhibitors |
| 04/18/2007 | EP1773847A2 Antibacterial agents |
| 04/18/2007 | EP1773846A1 Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 04/18/2007 | EP1773844A1 Compounds having affinity for the dopamine d3 receptor and uses thereof in medicine |
| 04/18/2007 | EP1773842A1 Pyrimidothiophene compounds |
| 04/18/2007 | EP1773841A1 Mixed solvate of olanzapine, method for preparing it and method for preparing form i of olanzapine therefrom |
| 04/18/2007 | EP1773837A2 Pyrrolotriazine kinase inhibitors |
| 04/18/2007 | EP1773836A1 Pyrrolopyrimidine derivatives useful in cancer treatment |
| 04/18/2007 | EP1773835A2 Pyrido-pyrido-pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 04/18/2007 | EP1773834A2 2, 8-disubstituted naphthyridine derivatives |
| 04/18/2007 | EP1773833A2 Pyrrolo(oxo)quinolines as 5ht ligands |
| 04/18/2007 | EP1773832A2 Dipeptidyl peptidase inhibitors |
| 04/18/2007 | EP1773831A1 Antibacterial agents |
| 04/18/2007 | EP1773830A1 Fused pyrimidones useful in the treatment and the prevention of cancer |
| 04/18/2007 | EP1773829A1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof |
| 04/18/2007 | EP1773828A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/18/2007 | EP1773827A1 Benzothiazole derivatives |
| 04/18/2007 | EP1773826A2 C-met modulators and method of use |
| 04/18/2007 | EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/18/2007 | EP1773823A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773820A1 Hair growth promoting agents |
| 04/18/2007 | EP1773819A1 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 04/18/2007 | EP1773818A2 Preparation of hydrochloride salts of tetrazole derivative |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773816A2 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1773815A2 Mitotic kinesin inhibitors |
| 04/18/2007 | EP1773814A2 Substituted oxindol derivatives and medicaments containing the same |
| 04/18/2007 | EP1773813A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 04/18/2007 | EP1773811A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt |
| 04/18/2007 | EP1773810A1 New 4-benzylidene-piperidin derivatives |
| 04/18/2007 | EP1773809A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/18/2007 | EP1773807A2 Kinase inhibitors |
| 04/18/2007 | EP1773805A1 Quinazolin-4-yl-piperidine and cinnolin-4-yl-piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 04/18/2007 | EP1773800A1 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof |
| 04/18/2007 | EP1773796A2 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 04/18/2007 | EP1773795A1 Substituted benzothiazoles |
| 04/18/2007 | EP1773791A1 Pyrrolotriazine compounds |
| 04/18/2007 | EP1773790A1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors |
| 04/18/2007 | EP1773788A2 Quinazoline derivatives |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773784A2 Anti-inflammatory medicaments |
| 04/18/2007 | EP1773782A1 Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
| 04/18/2007 | EP1773780A2 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773779A1 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 04/18/2007 | EP1773778A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 04/18/2007 | EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773774A2 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 04/18/2007 | EP1773773A1 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773772A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 04/18/2007 | EP1773771A2 Compounds and methods for treatment of thrombosis |
| 04/18/2007 | EP1773770A1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
| 04/18/2007 | EP1773769A1 Salt forms of atorvastatin |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773767A2 Syntheis of azo bonded immunoregulatory compounds |
| 04/18/2007 | EP1773766A2 Iap binding compounds |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773761A1 Histone deacetylase inhibitors |
| 04/18/2007 | EP1773757A1 Trpv1 agonists, formulations containing them and uses thereof |
| 04/18/2007 | EP1773750A1 Chemical compounds |
| 04/18/2007 | EP1773741A2 Synthesis of (-)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates and composition and uses thereof |
| 04/18/2007 | EP1773740A1 Neurologically-active compounds |
| 04/18/2007 | EP1773452A2 Lysis / resealing process and device for incorporating an active ingredient in erythrocytes |
| 04/18/2007 | EP1773451A2 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
| 04/18/2007 | EP1773409A1 A lock solution for medical devices |
| 04/18/2007 | EP1773405A2 Method of diagnosing, monitoring and treating pulmonary diseases |
| 04/18/2007 | EP1773404A2 Methylamine risks and treatment with n-derivatives of hyperactivity, depression and alcoholism |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773397A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 04/18/2007 | EP1773396A1 Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist |
| 04/18/2007 | EP1773382A2 Novel compositions and methods in cancer |
| 04/18/2007 | EP1773373A2 Method for modulating, regulating and/or stabilizing angiogenesis |
| 04/18/2007 | EP1773370A1 Combination therapies employing platelet aggregation drugs |
| 04/18/2007 | EP1773369A1 Pharmaceutical compositions and methods for peptide treatment |
| 04/18/2007 | EP1773363A1 Ngna compositions and methods of use |
| 04/18/2007 | EP1773362A1 Solvent based plant extracts |
| 04/18/2007 | EP1773359A1 Bis-quaternary ammonium salt corrosion inhibitors |
| 04/18/2007 | EP1773358A2 Biomaterial |
| 04/18/2007 | EP1773357A2 Compositions and methods of use of dimer digallates |
| 04/18/2007 | EP1773356A2 Insulin secretion by anthocyanins and anthocyanidins |
| 04/18/2007 | EP1773355A2 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 04/18/2007 | EP1773354A2 Vitamin b12 compositions |
| 04/18/2007 | EP1773353A2 Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfones |
| 04/18/2007 | EP1773352A2 Improved process for the preparation of oxidized phospholipids |
| 04/18/2007 | EP1773351A2 Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
| 04/18/2007 | EP1773350A2 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/18/2007 | EP1773349A2 Methods and compositions for treatment of preeclampsia |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1773347A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/18/2007 | EP1773346A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 04/18/2007 | EP1773345A2 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 04/18/2007 | EP1773344A1 Cyclic progestin regimens and kits |
| 04/18/2007 | EP1773343A1 Antibacterial agents |
| 04/18/2007 | EP1773342A1 Medicaments for treating chronic respiratory disease |